OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC. (April 2016) - Bezjak, A.; Paulus, R.; Gaspar, L.; Timmerman, R.D.; Straube, W.; Ryan, W.; Garces, Y.I.; Pu, A.T.; Singh, A.K.; Videtic, G.M.M.; McGarry, R.C.; Iyengar, P.; et al.